Magical Trade
Sunday, May 22, 2022
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Magical Trade
No Result
View All Result
Home Trade News

Cramer reluctant to buy market bounce, says ‘silly sellers’ could hit stocks again soon

by
November 29, 2021
in Trade News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

CNBC’s Jim Cramer said he doesn’t feel comfortable buying into Monday’s early stock market bounce, following Friday’s omicron-driven plunge, because the selling could resume in the event of future negative news about the highly mutated Covid variant.

The Dow Jones Industrial Average — which had been up nearly 400 points, or more than 1%, shortly after Wall Street’s open — gave up some of those gains. However, the S&P 500 and the Nasdaq were hanging on to most of their early session gains, advancing roughly 1% and nearly 1.5%, respectively. All three stock benchmarks sank more than 2% on Friday and finished lower last week.

RELATED POSTS

First baby formula shipment arrives from Europe on U.S. military plane

Conditions Are Ripe for a Deep Bear Market

Cramer said on “Squawk on the Street,” before Monday’s open, that he’s betting on science, including future reformulated Covid vaccines and promising new oral treatments, to mitigate the effects of omicron.

“I’m coming back as being sanguine. Not today. Because you get the market up and the same people buying today, if they see someone who landed” in the U.S. and has the omicron variant, “They’ll say, ‘I got to sell,'” the “Mad Money” host said. “We have to guard ourselves against silly sellers.”

No omicron cases have been found in the U.S. yet. But infections have been found in South Africa, where the variant was originally identified, as well as the U.K., Israel, Belgium, the Netherlands, Germany, Italy, Australia and Hong Kong.

Moderna CEO Stephane Bancel told CNBC he believes omicron is present in most nations. “I believe most countries that have direct flights from South Africa in the last seven to 10 days already have cases in their country that they may not be aware of.”

Bancel and Pfizer CEO Albert Bourla said in separate “Squawk Box” interviews Monday that their companies are working on omicron versions of their vaccines with the hope of getting them out next year.

Bourla said he expects Pfizer’s Covid treatment pill to be effective against the omicron variant. He added the company now expects to manufacture 80 million courses of the pill, an increase from its original manufacturing goal of 50 million courses.

Merck is also working on a Covid pill.

“You listen to Bourla and Bancel … and you come back and say, ‘Look, these guys are the people you have to bank on.’ They know the science,” Cramer said. “What that may mean is that these people solve it” and then if investors sold, “you have to buy back much higher.”

ShareTweetPin

Related Posts

First baby formula shipment arrives from Europe on U.S. military plane

by
May 22, 2022
0

A military cargo plane carrying the first shipment of infant formula from Europe to address a critical shortage in the...

Conditions Are Ripe for a Deep Bear Market

by
May 22, 2022
0

Previous bear markets have bottomed out when the Federal Reserve eased monetary policy. Photo: JOSHUA ROBERTS/REUTERS With the S&P 500...

Quarterly Starts by Purpose and Design: "Built for rent" Increasing

by
May 22, 2022
0

by Calculated Risk on 5/22/2022 11:48:00 AM Along with the monthly housing starts for April last week, the Census Bureau...

SpaceX looks to raise $1.7 billion in new funding, boosting its valuation to $127 billion

by
May 22, 2022
0

A Falcon 9 rocket launches a batch of Starlink satellites to orbit on April 29, 2022. SpaceX SpaceX is raising...

Series I Savings Bonds: What Readers Want to Know

by
May 22, 2022
0

The initial annualized rate on new Series I savings bonds sold from May through October of this year is 9.62%....

Next Post

Biden’s Blunder Could Send Oil Prices To $100

Hedge-fund investor who made $2.6 billion on pandemic trades says omicron could be bullish for stock market

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Fund manager believes FAANG is dead — says now it’s all about MANTA

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Bank of America names its top global tech stocks — including one it says has upside of 100%

    0 shares
    Share 0 Tweet 0
  • ‘Conviction sell’: UBS says avoid these global stocks amid rising headwinds

    0 shares
    Share 0 Tweet 0
  • These are the global stocks to own if stagflation hits, according to Credit Suisse

    0 shares
    Share 0 Tweet 0
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.magicaltrade.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.magicaltrade.net